Long-Term Follow-up and Mortality Rate of Patients of the Randomized Freeway Stent Study

CONCLUSION: The safety results presented support the recent conclusions that the use of paclitaxel technology does not lead to an increase in mortality. At the same time, the efficacy results clearly demonstrate that the potential benefits of drug-eluting balloon treatment are maintained over a 5-year period.PMID:38273128 | PMC:PMC10844456 | DOI:10.1007/s00270-023-03646-0

Source: Nuklearmedizin - January 25, 2024 Category: Radiology Authors: Klaus Hausegger Wiebke Kurre Henrik Schr öder Johannes Dambach Stefanie Stahnke Christian Loewe Karl Sch ürmann Roman Fischbach Jochen Textor Stephan Sch äfer Stephan M üller-Hülsbeck Source Type: research